Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott Laboratories' Upcoming Earnings: What You Need to Know
Motley Fool
Friday, July 13, 2012 - 12:20pm
tags:
Abbott Laboratories, earnings
Johnson & Johnson, shareholders near deal on lawsuit over legal issues, recalls
Yahoo/AP
Friday, July 13, 2012 - 12:14pm
tags:
JNJ, recalls
What’s In A Name? A New Fight Over Biosimilars
Pharmalot
Thursday, July 12, 2012 - 7:40pm
tags:
biosimilars
Prolor Biotech Is Worth An Investor's Research
Seeking Alpha
Thursday, July 12, 2012 - 7:34pm
tags:
Prolor
Why ImmunoGen Shares Plunged
Motley Fool
Thursday, July 12, 2012 - 7:32pm
tags:
Immunogen, Roche
Actelion Plans To Cut 135 Jobs, Refocus Research Effort
Bloomberg
Thursday, July 12, 2012 - 7:30pm
tags:
layoffs, reorganization, Actelion
Can Vivus Follow Arena’s Victory in 5 Days?
Wall St. Cheat Sheet
Thursday, July 12, 2012 - 7:28pm
tags:
Vivus, Arena Pharmaceuticals, Belviq, Qnexa, obesity
AstraZeneca acquires neuroscience assets from Link Medicine
Yahoo/Fly on the Wall
Thursday, July 12, 2012 - 12:34pm
tags:
Link Medicine, AstraZeneca, M&A
Rigel's Fostamatinib and the Future of Rheumatoid Arthritis Therapy
Yahoo/Reuters
Thursday, July 12, 2012 - 11:28am
tags:
rheumatoid arthritis, Rigel, fostamatinib
Can These 3 Companies Take Down Gilead?
Motley Fool
Thursday, July 12, 2012 - 11:27am
tags:
Gilead, HIV, ViiV Healthcare, Shionogi, Merck, Bristol-Myers Squibb
Why Big Pharma Won't Get Its Piece Of The $1.2 Trillion Global Drug Market
Forbes
Thursday, July 12, 2012 - 11:26am
tags:
emerging markets, generics, patents, Big Pharma
Merck Hits 4-Year High As Osteoporosis Drug Shines
Investors.com
Thursday, July 12, 2012 - 11:23am
tags:
Merck, osteoporosis, Odanacatib
Lingering Concerns about Qnexa's Safety
Motley Fool
Thursday, July 12, 2012 - 10:59am
tags:
Qnexa, obesity, Vivus
Questcor: Why Analysts Are Improving Its Ratings Now
Seeking Alpha
Thursday, July 12, 2012 - 10:58am
tags:
Questcor, Alkermes, Arena Pharmaceuticals, Vivus, Orexigen
Can Exelixis Continue Making Big Moves?
Seeking Alpha
Thursday, July 12, 2012 - 10:56am
tags:
Exelixis, cabozantinib
Arena files for approval of Belviq in Switzerland
Yahoo/AP
Thursday, July 12, 2012 - 10:55am
tags:
Switzerland, obesity, Arena Pharmaceuticals, Belviq
Vivus: A New Twist On The Qnexa Story
Seeking Alpha
Thursday, July 12, 2012 - 10:54am
tags:
Qnexa, Vivus, obesity
GlaxoSmithKline says data from diabetes drug study positive
Yahoo/Fly on the Wall
Wednesday, July 11, 2012 - 12:45pm
tags:
GSK, diabetes, albiglutide
4 Small-Cap Pharma Stocks With Zero Debt To Consider Currently
Seeking Alpha
Wednesday, July 11, 2012 - 12:42pm
tags:
Osiris, Depomed, Opexa, Neurostem
Coming Soon: Johnson & Johnson Earnings
Motley Fool
Wednesday, July 11, 2012 - 12:39pm
tags:
earnings, JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.